Should we use poor prognosis factors to start early treatment in patients with rheumatoid arthritis?

Authors :: Valor L
de la Torre Ortega I
Source :: Reumatologia clinica [Reumatol Clin] 2012 Jul-Aug; Vol. 8 (4), pp. 163-7. Date of Electronic Publication: 2012 Feb 07.
Publication Year :: 2012

Subjects :: Antigens, Bacterial immunology
Antirheumatic Agents administration & dosage
Arthritis, Rheumatoid blood
Arthritis, Rheumatoid immunology
Autoantibodies analysis
Autoantibodies blood
Biomarkers
Citrulline analysis
Drug Administration Schedule
Drug Therapy, Combination
HLA-D Antigens immunology
Humans
Methotrexate administration & dosage
Methotrexate therapeutic use
Molecular Mimicry
Peptides analysis
Peptides immunology
Porphyromonas gingivalis immunology
Precision Medicine
Prognosis
Protein Processing, Post-Translational
Protein Tyrosine Phosphatase, Non-Receptor Type 22 genetics
Protein Tyrosine Phosphatase, Non-Receptor Type 22 immunology
Rheumatoid Factor blood
Risk Factors
Synovial Fluid chemistry
Tumor Necrosis Factor-alpha antagonists & inhibitors
Antirheumatic Agents therapeutic use
Arthritis, Rheumatoid drug therapy

Full Text Access

Tools